cognitive cybersecurity intelligence

News and Analysis


Pfizer Australia and BioNTech announce TGA approval for Omicron XBB.1.5-adapted monovalent COVID-19 vaccine

The Therapeutic Goods Administration (TGA) has approved Pfizer Australia and BioNTech SE’s XBB.1.5-adapted monovalent COVID-19 vaccine (COMIRNATY® Omicron XBB.1.5) for individuals aged 5 and over. The decision follows evidence that this vaccine can better protect against symptomatic and severe COVID-19. The vaccine is free and available at pharmacies and general practices across Australia.

Source: –

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts

A Better Connected Care Journey

The article urges healthcare organizations to move towards integrated, digitally enabled care delivery, replacing outdated point solutions. It acknowledges some may need help overcoming hurdles.